Flu Drugs May Combat Cognitive Decline, Aging Ills
Researchers at Northwestern University have discovered that certain flu medications may help prevent cognitive decline and premature aging by protecting essential sugar molecules in the body. The study, conducted on blood samples and mice, suggests these drugs could potentially be repurposed to treat aging-related conditions like dementia.
Why it matters
This discovery offers a potential new therapeutic pathway for addressing cognitive impairment in patients with chronic viral infections and provides insights into broader aging-related neurological diseases.
A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and extended into preclinical drug trials.
The article presents scientific findings from a peer-reviewed study in a factual, objective manner without ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in